CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Peptinov is developing an active immunotherapy to treat osteoarthritis by targeting a key protein that drives inflammation. This approach aims to stimulate the immune system to produce antibodies against interleukin-6, potentially halting cartilage damage and disease progression, with a cost-effective treatment option.
Osteoarthritis is a debilitating disease affecting the joint and a leading cause of disability worldwide.
It affects at least 250m people and incurs healthcare costs of toward 0.5% of the GDP.
Peptinov is developing an active immunotherapy that can halt inflammation-driven destruction of the cartilage in the joints.
We use a unique approach to neutralise a key pro-inflammatory protein (IL-6) driving chronic inflammation.
Our vaccine-like approach stimulates the patients own immune system to prod…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
